[Federal Register Volume 89, Number 12 (Thursday, January 18, 2024)]
[Notices]
[Page 3494]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00858]



[[Page 3494]]

-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice: 12309]


Termination of Iran, North Korea, and Syria Nonproliferation Act 
Measures Against an Indian Entity

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: A determination has been made, pursuant to the Iran, North 
Korea, and Syria Nonproliferation Act, to terminate nonproliferation 
measures pursuant to this Act on an Indian entity.

DATES: January 18, 2024.

FOR FURTHER INFORMATION CONTACT: Pam Durham, Office of Missile, 
Biological, and Chemical Nonproliferation, Bureau of International 
Security and Nonproliferation, Department of State, Telephone (202) 
647-4930, Email [email protected].

SUPPLEMENTARY INFORMATION: Pursuant to the Iran, North Korea, and Syria 
Nonproliferation Act (Pub. L. 109-353), the U.S. Government decided on 
December 28, 2023 to terminate measures initially imposed on October 
14, 2022 (see Volume 87 FR Public Notice 11887) on the Indian entity 
Synnat Pharma Pvt Ltd, and any successor, sub-unit, or subsidiary 
thereof.

Choo S. Kang,
Assistant Secretary for International Security and Nonproliferation, 
Department of State.
[FR Doc. 2024-00858 Filed 1-17-24; 8:45 am]
BILLING CODE 4710-27-P